[Table of Contents]

Volume: 25S1 - May 1999

Sexually Transmitted Diseases in Canada: 1996 Surveillance Report
(with Preliminary 1997 Data)

Human papillomavirus

Human papillomavirus (HPV) has never been nationally notifiable in Canada, even in its clinically manifested form of genital warts. As a result, national prevalence rates for HPV are difficult to estimate. Without surveillance data, researchers have to rely on incidental data such as laboratory testing results, research studies and prevalence/incidence rates of cervical cancer to make inferences about HPV prevalence in Canada. Table 2 shows the laboratory test results for HPV specimens, provided by the National Laboratory for Viral Oncology, from 1994 to 1996. Figure 12 shows the incidence and mortality rates for cervical cancer over the same period of time, provided by the Cancer Bureau of LCDC.

Table 2 Cervical specimens: typing of human papillomavirus, 1996

FIGURE 12 Cervical Cancer: Incidence and Mortality per 100,000 Females, Canada, 1990-1998

Source: Canadian Cancer Statistics, 1990 to 1998, National Cancer Institute of Canada, Statistics Canada, Provincial/Territorial Cancer Registries, Health Canada. © 1999

[Previous] [Table of Contents] [Next]